Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. (Q48598672)

13 February 2018

title

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. (English)

1 reference

13 February 2018

0 references

0 references

Gurley BJ

1

1 reference

13 February 2018

Swain A

2

1 reference

13 February 2018

Hubbard MA

3

1 reference

13 February 2018

Hartsfield F

4

1 reference

13 February 2018

Thaden J

5

1 reference

13 February 2018

Williams DK

6

1 reference

13 February 2018

Gentry WB

7

1 reference

13 February 2018

Tong Y

8

1 reference

13 February 2018

language of work or name

English

0 references

publication date

9 May 2007

1 reference

13 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

13 February 2018

volume

83

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

61-69

1 reference

13 February 2018

Increasing trends in elderly persons' use of nonvitamin, nonmineral dietary supplements and concurrent use of medications

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Factors associated with dietary supplement use among prescription medication users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Herbal interactions involving cytochrome p450 enzymes: a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetic interactions between herbal remedies and medicinal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Interactions of herbs with cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Inhibition of human cytochrome P450 activities by kava extract and kavalactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Composition and biological activity of traditional and commercial kava extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Influence of Goldenseal Root on the Pharmacokinetics of Indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

In vitro approaches to predicting drug interactions in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Kinetics of kavain and its metabolites after oral application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Phytochemical Assays of Commercial Botanical Dietary Supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

High-performance liquid chromatography determination of hydrastine and berberine in dietary supplements containing goldenseal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

Identification of some human urinary metabolites of the intoxicating beverage kava

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100222

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100222

1 reference

13 February 2018

1 reference

13 February 2018